Summary
NHS England has paused new prescriptions of cross-sex hormones for teenagers aged 16 and 17 who are questioning their gender identity. This decision follows a review that found the evidence on the effects of these hormones was too weak to determine their benefits or harms. Young people already receiving these hormones can continue, but their treatments will be reviewed.
Key Facts
- NHS England stopped giving new hormone prescriptions to 16 and 17-year-olds questioning their gender.
- This pause came after a review found weak evidence on the hormones' effects on teenagers.
- Hormones can cause permanent changes, like a deeper voice or breast growth.
- The decision affects a small number of teenagers, and a consultation for future guidance is underway.
- Under existing rules, such hormones are not given to children under 16.
- Ongoing support will be offered at three NHS gender clinics for children in England.
- The move follows a major report by Dr. Hilary Cass, highlighting weak evidence in children's gender care.
- Trans advocacy groups have expressed concern and may consider legal action.
